top of page

Facilitate collaboration and information exchange across Australian jurisdictions to develop the necessary health infrastructure for HCV testing and treatment in custodial settings nationally.

Picture 1_edited_edited_edited_edited.jpg
The Australian hepatitis and risk survey in prisons (AusHep) 
NPHN_Logo_Colour_RGB.png
AusHep logo.jpg
NPHN_Logo_Colour_RGB.png

OVERVIEW

AusHep is a Commonwealth-supported national prison-based blood-borne virus surveillance program that assesses the prevalence, risk behaviours, and care cascades for hepatitis C, hepatitis B, and HIV in the Australian prison sector. The first round of AusHep was conducted in 2023-2023 and the second round is planned to commence in 2025.

 

AusHep fills a critical gap in national prison-based blood-borne virus surveillance and serves as a mechanism for effective monitoring of the prison-based contributions to the national and state-based investments in the push to eliminate hepatitis C and hepatitis B as public health threats. AusHep replaces the previous triennial National Prison Entrants Blood-Borne Virus Survey (NPPBVS; 2004 - 2016) as the key national prison-based blood-borne virus surveillance program.​​

hDJGX8vf.jpeg
NPHN_Logo_Colour_RGB.png

OBJECTIVES

The objectives of AusHep are to:

  • monitor the prevalence of hepatitis C, hepatitis B and HIV (including exposure, current infection, immunity  and reinfection) in the Australian prison sector;

  • monitor the engagement in blood-borne virus care cascades (i.e. engagement in testing and treatment)  among people in prison;

  • collect important health and risk behaviour data (e.g. injecting practices, harm reduction access) among  people in prison.

​

The bio-behavioural survey involves point-of-care testing for hepatitis C antibodies, hepatitis C RNA (if antibody positive), hepatitis B surface antigens, and HIV antibodies and an interview-style survey.

 

The first round of AusHep was conducted in 2023-2023 in 23 representative prisons and involved 1599 randomly selected participants from six states and territories. 

NPHN_Logo_Colour_RGB.png

KEY FINDINGS

To read about the AusHep study methods and results (round one; 2022-2023) – access the publications here. 

To explore AusHep data (round one; 2022-2023), visit the NPHN Surveillance Dashboard here.

PARTNERSHIP & FUNDERS

NPHN_Logo_Colour_RGB.png

AusHep was initiated with funding through strategic research and surveillance funding provided to the Kirby Institute from the Commonwealth Department of Health and Ageing and is now funded through an NHMRC Partnership Project. AusHep is an NPHN initiative led by researchers at the Kirby Institute in partnership with state and territory sector stakeholders.​ Partner organisations from AusHep Round 1 include:

  • Corrective Services NSW

  • Justice Health NSW

  • NT Department of Correctional Services

  • NT Department of Health

  • QLD Corrective Services

  • QLD Office of Prisoner Health & Wellbeing (QLD Health)

  • SA Department of Corrective Services

  • SA Prison Health Services

  • Correctional Primary Health Services (TAS)

  • Tasmanian Prison Service 

  • WA Department of Justice

NPHN_Logo_Colour_RGB.png

CONTACT

For any questions about AusHep, please contact:
Lana Pasic, AusHep Study Coordinator
lpasic@kirby.unsw.edu.au

©2025 by National Prisons Hepatitis Network (NPHN). All rights reserved.

Photography: Conor Ashleigh www.conorashleigh.com 

bottom of page